Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-22T15:22:50.358Z Has data issue: false hasContentIssue false

Delayed-onset nocturnal akathisia due to risperidone and levomepromazine: a case report

Published online by Cambridge University Press:  16 April 2020

E. Shimizu*
Affiliation:
Department of Psychiatry (K2), Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japan
H. Watanabe
Affiliation:
Department of Psychiatry (K2), Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japan
M. Iyo
Affiliation:
Department of Psychiatry (K2), Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japan
*
*Corresponding author. E-mail address:[email protected] (E. Shimizu).
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case report
Copyright
Copyright © European Psychiatric Association 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sachdev, P. The development of the concept of akathisia: a historical overview. Schizophr Res 1995;16 (1):33–45.CrossRefGoogle ScholarPubMed
Walters, ASHening, WRubinstein, M et al. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep 1991;14(4):339–45.Google ScholarPubMed
Lal, SNair, NP. Is levomepromazine a useful drug in treatment-resistant schizophrenia? Acta Psychiatr Scand 1992;85(3):243–5.Google ScholarPubMed
Blaisdell, GD. Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 1994;27 (4):139—46.CrossRefGoogle ScholarPubMed
Miller, CHMohr, FUmbricht, D et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 1998;59 (2):69–75.Google ScholarPubMed
Meltzer, HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21(2 Suppl):106S–15S.CrossRefGoogle ScholarPubMed
Lal, SNair, NPCecyre, D et al. Levomepromazine receptor binding profile in human brain-implications for treatment-resistant schizophrenia. Acta Psychiatr Scand 1993;87(6):380–3.Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.